Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive overview of Artemisinin and its derivatives as anticancer agents
Zi-wei Zeng, Di Chen, Lei Chen, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115000-115000
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Drug repurposing for cancer therapy
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 75
Dual-targeting nanozyme combined with aPD-L1-based immunotherapy for combating cancer recurrence and metastasis
Lu Tang, Yuqi Cao, Yue Yin, et al.
Materials Today (2024) Vol. 73, pp. 79-95
Closed Access | Times Cited: 16
Endoperoxide‐enhanced self‐assembled ROS producer as intracellular prodrugs for tumor chemotherapy and chemodynamic therapy
Junjie Tang, Yadong Liu, Yifan Xue, et al.
Exploration (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 12
Self-assembled nanodrug delivery systems for anti-cancer drugs from traditional Chinese medicine
Li Qiao, Yuan Lianghao, Gao Shijie, et al.
Biomaterials Science (2024) Vol. 12, Iss. 7, pp. 1662-1692
Closed Access | Times Cited: 11
Molecular mechanisms and therapeutic applications of huaier in breast cancer treatment
Ke-fei Luo, Linxi Zhou, Zi-wei Wu, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 6
Anti-tumor Effects of Artemisinin-Based Oligomers: From Monomer to Trimer as a Novel Drug-Enhancing Strategy
Bei Jiang, Jiaoying Wang, Lin Yue, et al.
European Journal of Medicinal Chemistry (2025), pp. 117313-117313
Closed Access
Hydrophilic imprinted MnO2 nanowires “coating” membrane with ultrahigh adsorption capacity for highly selective separation of Artemisinin/Artemether
Minjia Meng, Yi Li, Hui Peng, et al.
Chemical Engineering Journal (2023) Vol. 466, pp. 143020-143020
Closed Access | Times Cited: 16
Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy
Fahad Khan, Pratibha Pandey, Meenakshi Verma, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116363-116363
Open Access | Times Cited: 4
Discovery of harmiprims, harmine-primaquine hybrids, as potent and selective anticancer and antimalarial compounds
Kristina Pavić, Goran Poje, Laís Pessanha de Carvalho, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 105, pp. 117734-117734
Closed Access | Times Cited: 4
Facilitated Drug Repurposing with Artemisinin-Derived PROTACs: Unveiling PCLAF as a Therapeutic Target
Yan Li, Zi Wei Zeng, Di Chen, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 11335-11350
Closed Access | Times Cited: 12
Artemisinins: Promising drug candidates for the treatment of autoimmune diseases
Xu Gao, Xian Lin, Qingwen Wang, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 867-891
Closed Access | Times Cited: 8
Multifunctional Deep Eutectic Solvent-Based Microemulsion for Transdermal Delivery of Artemisinin
Menghan Li, Jing Yuan, Z.H. Liu, et al.
Langmuir (2024) Vol. 40, Iss. 10, pp. 5098-5105
Closed Access | Times Cited: 2
Dihydroartemisinin inhibits tumor progress via blocking ROR1-induced STAT3-activation in non-small cell lung cancer
Yanping Li, Haoyi Sun, Caihong Bai, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112157-112157
Closed Access | Times Cited: 2
Blocking the WNT/β-catenin pathway in cancer treatment:pharmacological targets and drug therapeutic potential
Xi Zhao, Yunong Ma, Jiayang Luo, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35989-e35989
Open Access | Times Cited: 2
Dihydroartemisinin inhibited vasculogenic mimicry in gastric cancer through the FGF2/FGFR1 signaling pathway
Huina Wang, Qingzhu Ding, Haihua Zhou, et al.
Phytomedicine (2024) Vol. 134, pp. 155962-155962
Open Access | Times Cited: 2
Artemisinin and Its Derivatives as Potential Anticancer Agents
L Y Wen, Ben Chung-Lap Chan, Ming‐Hua Qiu, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3886-3886
Open Access | Times Cited: 2
Separation and Identification of Terpenoids in Three Pineapple Fibers Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry
Yijun Liu, Yuliang Chen, Jiameng Liu, et al.
Journal of Natural Fibers (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
In Vitro and In Silico Anti-Glioblastoma Activity of Hydroalcoholic Extracts of Artemisia annua L. and Artemisia vulgaris L.
Jurga Bernatonienė, Emilija Nemickaite, Daiva Majienė, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2460-2460
Open Access | Times Cited: 1
Progress of natural sesquiterpenoids in the treatment of hepatocellular carcinoma
Xiaodong Wang, Fancheng Meng, Jingxin Mao
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Design, Synthesis, and Antitumor Activities of Isomers of Artemisinin Dimer Derivatives
Lingyun Yue, Yanna Pan, Jiaoying Wang, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 7
Closed Access | Times Cited: 5
Design, Synthesis, and Antitumor Activity Evaluation of Artemisinin Bivalent Ligands
Hui Zhong, Qi Jiang, Cong Wu, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 409-409
Open Access | Times Cited: 1
Modulation of the Antimelanoma Activity Imparted to Artemisinin Hybrids by the Monoterpene Counterpart
Elisa De Marchi, Silvia Filippi, Silvia Cesarini, et al.
(2024)
Open Access | Times Cited: 1
Exploring novel camphor-derived heterocycles for antimalarial activity: Design, virtual screening, DFT, and molecular docking investigations
Anjaneyulu Bendi, Anirudh Singh Bhathiwal, D. S. Ramakrishna, et al.
Journal of Molecular Liquids (2024) Vol. 409, pp. 125506-125506
Closed Access | Times Cited: 1
Phytochemical Analysis and In Vivo Antimalarial Activities of Ethyl Acetate Fraction of Spilanthes filicaulis on Mice Subjected to Plasmodium berghei
Bankole Emmanuel Ofeniforo, Olalekan Bukunmi Ogunro, Charles Ebere Dike, et al.
Vector-Borne and Zoonotic Diseases (2024) Vol. 25, Iss. 1, pp. 26-33
Closed Access | Times Cited: 1
Development of natural product-based targeted protein degraders as anticancer agents
Cheng Chen, Yanyan Feng, Chen Zhou, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107772-107772
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top